Keyphrases
Drug Development
100%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
100%
Reporter Expression
100%
Degenerative Disease
100%
Early Biomarker
100%
TAR DNA-binding Protein 43 (TDP-43)
100%
Recent Advances
50%
Therapeutic Intervention
50%
Clinical Trials
50%
Oxidative Stress
50%
Cellular Stress
50%
DNA Damage
50%
Inflammation
50%
P53 Pathway
50%
Disease Progression
50%
Clinical Signs
50%
Reporter Mice
50%
Specific Mechanisms
50%
Neurodegenerative Diseases
50%
Cellular Damage
50%
Histological Analysis
50%
In Vivo Reporter
50%
HMOX1
50%
Biochemistry, Genetics and Molecular Biology
P53
100%
Transactive Response Dna Binding Protein-43
100%
Cell Damage
50%
Clinical Trial
50%
P21
50%
Oxidative Stress
50%
Cell Stress
50%
DNA Damage
50%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Development
100%
Amyotrophic Lateral Sclerosis
100%
Biological Marker
40%
Protein P53
40%
Cytoprotective Agent
40%
Degenerative Disease
40%
Clinical Trial
20%
Disease Exacerbation
20%
Inflammation
20%
Immunology and Microbiology
P53
100%
Transactive Response Dna Binding Protein-43
100%
Oxidative Stress
50%
Cell Stress
50%
DNA Damage
50%
Cell Damage
50%
Neuroscience
In Vivo
100%
Amyotrophic Lateral Sclerosis
100%
P53
40%
Oxidative Stress
20%
DNA Damage
20%
Cell Damage
20%
Cell Stress
20%
Neurodegenerative Disorder
20%